Clinical Trials Logo

Filter by:
NCT ID: NCT02201550 Completed - Clinical trials for Type 2 Diabetes Mellitus

Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide

Start date: February 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine the effect of exogenous glucagon-like peptide-1 on the immune system i.e on the regulation of immune cells important in diseases such as obesity and diabetes. The hypotheses are: - Glucagon-like peptide-1 has an immunological effect observed by studying immune cells in the blood - Treatment with glucagon-like peptide-1 increases the number of immune cells in the blood - Treatment with glucagon-like peptide-1 leads to a more anti-inflammatory cytokine profile in the blood

NCT ID: NCT02200731 Completed - Childhood Cancer Clinical Trials

FAMily Oriented Support (FAMOS): Psychosocial Intervention for Childhood Cancer Survivors and Their Families

Start date: July 2014
Phase: N/A
Study type: Interventional

To investigate whether a home-based psychosocial family intervention that takes place shortly after ending the primary medical treatment can help families adjust to their cancer-related psychological issues.

NCT ID: NCT02200016 Completed - Postoperative Pain Clinical Trials

Displacement of Popliteal Sciatic Nerve Catheters After Major Foot and Ankle Surgery

Start date: November 2014
Phase: Phase 4
Study type: Interventional

Displacement of popliteal sciatic nerve catheters after major foot and ankle surgery. A randomized controlled double blinded MRI study comparing long versus short axis catheter placement. Which procedure for insertion of nerve catheters for postoperative pain after major foot and ankle surgery is the best

NCT ID: NCT02197416 Completed - Clinical trials for Venous Thromboembolism

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Start date: September 29, 2014
Phase: Phase 3
Study type: Interventional

This open-label, single arm prospective cohort study will assess the safety of dabigatran etexilate in secondary prevention of venous thromboembolism in paediatric patients. Children from 0 to less than 18 years of age will be eligible to participate.

NCT ID: NCT02196727 Completed - Postoperative Pain Clinical Trials

Evaluation of Postoperative Pain Following Bascom Cleft Lift Operation

Start date: May 2013
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate postoperative pain in Bascom Cleft Lift operation receiving multimodal analgesia in day-case surgery setting. Hypothesis: Multimodal analgesia provides adequate pain relief in patients undergoing Bascom Cleft Lift operation.

NCT ID: NCT02194985 Completed - Fabry Disease Clinical Trials

Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease

Start date: March 14, 2015
Phase: Phase 3
Study type: Interventional

This is an open-label extension study intended to provide continued treatment with migalastat hydrochloride (HCl) for participants with Fabry disease who completed treatment of a previous migalastat HCl study. The study assessed the long-term safety and effectiveness of migalastat HCl.

NCT ID: NCT02192853 Completed - Clinical trials for Type 2 Diabetes Mellitus

Correlation Between Plasma- and Endothelial DPP-4 Activity

Start date: May 2013
Phase: Phase 4
Study type: Interventional

The investigators want to estimate both the endothelial and the plasma activity of dipeptidyl peptidase 4 during different doses of sitagliptin in healthy subjects and patients with type 2 diabetes. Furthermore, the investigators want to investigate whether the current clinical dose of 100 mg of sitagliptin is sufficient to inhibit both the plasma and the endothelial activity of the enzyme dipeptidyl peptidase 4.

NCT ID: NCT02192606 Completed - Pelvic Pain Clinical Trials

Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?

3DRCT
Start date: November 2013
Phase: N/A
Study type: Interventional

The objective aim is to evaluate whether the use of 3D laparoscopy facilitates the vaginal cuff closure of the vaginal cuff during a total laparoscopic hysterectomy among novice laparoscopists (PGY 2-4, Fellow). This is a randomized single blinded controlled trial comparing the difference in 2D vs. 3D in regards to vaginal cuff closure time stratified by residents and fellows. Patients will undergo a total laparoscopic hysterectomy and will be randomized to either 2D versus 3D.

NCT ID: NCT02192450 Completed - Clinical trials for Type 1 Diabetes Mellitus

Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia

HypoDeg
Start date: January 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether insulin degludec compared to insulin glargine can reduce the risk of symptomatic nocturnal hypoglycaemia in subjects with the greatest potential benefit from optimised insulin treatment, which are patients with type 1 diabetes and high risk of nocturnal severe hypoglycaemia.

NCT ID: NCT02191514 Completed - Stroke Clinical Trials

Prehospital Management of Stroke Patients by Emergency Medical Services

Start date: July 2014
Phase: N/A
Study type: Observational

Annually 12.000 people i Denmark suffer from a stroke. Treatment for ischemic stroke is available, but only 12% of stroke patients receive it. The treatment is only available within a time frame of 4,5 hours from symptom onset, thus the Emergency Medical Services (EMS) is essential to fast and effective stroke treatment. The aim of this study is: 1. To establish the rate of recognition of stroke symptoms by healthcare personnel in the EMD, ultimately aiming at optimizing performance, and identifying barriers for a fast and correct EMS-response. 2. To assess prehospital time consumption by ambulance personnel on the scene of a stroke, create a baseline for future comparison and generate explorative hypotheses for forthcoming interventions. The overall aim of this study is, to ensure the best possible prehospital care for all stroke patients. The study will determine, if the EMD is at a high and international level in regards to stroke recognition, and if there is a potential to decrease on-scene time. This will serve as future comparison and have an effect on the structure and future education in the prehospital services, and potentially improve the outcome after acute ischemic stroke.